| Literature DB >> 34466047 |
Binbin Zhao1, Yanhua Wu2, Xiaoying Jin1, Lihong Yang2, Jian Yang1,2, Xiancang Ma1, Bin Yan1,2.
Abstract
OBJECTIVE: Sleep disorders are associated with the prevalence of stroke. However, there is limited evidence regarding the association between objectively measured sleep characteristics and ischemic stroke.Entities:
Keywords: Sleep Heart Health Study; ischemic stroke; polysomnography; sleep characteristics
Year: 2021 PMID: 34466047 PMCID: PMC8403018 DOI: 10.2147/NSS.S313891
Source DB: PubMed Journal: Nat Sci Sleep ISSN: 1179-1608
Figure 1Inclusion and exclusion criteria for the study population. This figure depicts the inclusion of patients into the current investigation as a flowchart. The arrows that branch off represent patients that did not meet the criteria and were excluded.
Descriptive Characteristics by WASO Quartile (Quartile I: <30.0min; Quartile II: 30.0min–48.5min; Quartile III:49.0min-80.0min; Quartile IV: >80.0min)
| Characteristics | Total (n=4204) | WASO (Min) | ||||
|---|---|---|---|---|---|---|
| First Quartile (n=1048) | Second Quartile (n=1063) | Third Quartile (n=1047) | Fourth Quartile (n=1046) | P value | ||
| Age, year | 63.8±11.1 | 59.2±11.0 | 61.7±10.6 | 65.5±10.3 | 68.7±10.2 | <0.001 |
| Gender, n (%) | <0.001 | |||||
| Male | 1978 (47.1) | 405 (38.6) | 470 (44.2) | 537 (51.3) | 566 (54.1) | – |
| Female | 2226 (52.9) | 643 (61.4) | 593 (55.8) | 510 (48.7) | 480 (45.9) | – |
| Body mass index, kg/m2 | 28.2±5.0 | 28.2±5.2 | 28.0±4.9 | 28.4±4.8 | 28.4±5.0 | 0.122 |
| Race, n (%) | 0.076 | |||||
| White | 3668 (87.3) | 907 (86.5) | 919 (86.5) | 938 (89.6) | 904 (86.4) | – |
| Other | 536 (12.7) | 141 (13.5) | 144 (13.5) | 109 (10.4) | 142 (13.6) | – |
| Smoking status, n (%) | 0.044 | |||||
| Smoker | 2260 (53.8) | 546 (52.1) | 549 (51.7) | 568 (54.3) | 597 (57.2) | – |
| Never smoker | 1938 (46.2) | 502 (47.9) | 512 (48.3) | 478 (45.7) | 446 (42.8) | – |
| Alcohol use, n (%) | 0.170 | |||||
| At least 1 drink per day | 1708 (43.3) | 419 (42.9) | 457 (45.9) | 399 (41.0) | 433 (43.3) | – |
| None | 2238 (56.7) | 557 (57.1) | 538 (54.1) | 575 (59.0) | 568 (56.7) | – |
| Benzodiazepine use, n (%) | 246 (5.9) | 48 (4.6) | 65 (6.1) | 59 (5.6) | 74 (7.1) | 0.105 |
| Diabetes mellitus, n (%) | 295 (7.0) | 55 (5.2) | 53 (5.0) | 93 (8.9) | 94 (9.0) | <0.001 |
| Hypertension, n (%) | 1681 (40.0) | 309 (29.5) | 382 (35.9) | 447 (42.7) | 543 (51.9) | <0.001 |
| AHI, events/h | 9.9±13.0 | 7.8±11.2 | 8.9±12.2 | 10.3±12.5 | 12.5±15.4 | <0.001 |
| Sleep duration, h | 7.3±0.9 | 7.0±1.0 | 7.2±0.9 | 7.4±0.9 | 7.7±0.8 | <0.001 |
| SE, % | 83.4±10.0 | 91.6±5.5 | 88.0±4.5 | 82.7±4.9 | 71.1±9.5 | <0.001 |
| REM, % | 19.7±6.8 | 21.3±6.6 | 20.3±6.3 | 19.3±6.7 | 17.8±7.1 | <0.001 |
| SWS, % | 17.5±11.9 | 19.9±12.1 | 18.3±11.4 | 15.9±11.5 | 16.0±12.2 | <0.001 |
| SL, min | 12.8±19.5 | 14.0±21.5 | 12.4±18.6 | 12.7±18.5 | 12.2±19.2 | 0.177 |
| Total ArI, events/h | 19.0±10.4 | 15.4±8.6 | 18.0±8.8 | 20.1±10.0 | 22.7±12.3 | <0.001 |
| ArI-REM, events/h | 15.2±10.8 | 13.7±10.0 | 15.0±10.6 | 15.3±10.2 | 16.7±12.3 | <0.001 |
| ArI-NREM, events/h | 19.9±11.3 | 15.8±9.3 | 18.7±9.5 | 21.2±11.2 | 24.0±13.3 | <0.001 |
| SFI, events/h | 8.9±3.4 | 7.4±2.6 | 8.5±2.8 | 9.0±3.0 | 10.5±4.2 | <0.001 |
| Follow-up time, year | 10.7±3.0 | 11.2±2.7 | 11.0±2.8 | 10.7±2.9 | 10.0±3.4 | <0.001 |
Notes: Results are presented as mean ± standard deviation or n (%). The P values represent the difference among four groups.
Abbreviations: AHI, apnea hypopnea index; ArI, arousal index; NREM, non-rapid eye movement; REM, rapid eye movement; SFI, sleep fragmentation index; SL, sleep latency; SWS, slow wave sleep; WASO, wake after sleep onset.
Figure 2Kaplan-Meier plots of cumulative risk for ischemic stroke stratified by WASO quartiles ((A); quartile I <30.0 min; quartile II: 30.0 min-48.5 min; quartile III: 49.0 min-80.0 min; quartile IV: >80.0 min) and SE ((B); quartile I <80%, quartile II: 80%-84.9%, quartile III: 85%-89.9%, and quartile IV: ≥90%).
HRs and 95% CIs for Sleep Characteristics Associated with Ischemic Stroke
| Univariable Models | Multivariable Adjusted† | Multivariable Adjusted‡ | ||||
|---|---|---|---|---|---|---|
| Sleep Variables | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
| WASO | 1.008 (1.005–1.011) | <0.001 | 1.003 (1.000–1.007) | 0.049 | 1.004 (1.000–1.008) | 0.028 |
| SE | 0.964 (0.951–0.977) | <0.001 | 0.980 (0.966–0.995) | 0.011 | 0.981 (0.966–0.996) | 0.012 |
| REM, % | 0.971 (0.947–0.995) | 0.017 | 0.993 (0.969–1.019) | 0.598 | 0.994 (0.970–1.020) | 0.665 |
| SWS, % | 0.993 (0.978–1.008) | 0.361 | 0.992 (0.977–1.008) | 0.346 | 0.992 (0.976–1.007) | 0.300 |
| SL | 1.003 (0.994–1.011) | 0.551 | 1.002 (0.993–1.011) | 0.639 | 1.002 (0.993–1.010) | 0.693 |
| SFI | 1.036 (0.987–1.087) | 0.149 | 1.007 (0.959–1.057) | 0.780 | 1.006 (0.958–1.056) | 0.815 |
| Total ArI | 1.002 (0.985–1.019) | 0.798 | 0.992 (0.972–1.013) | 0.462 | 0.992 (0.972–1.013) | 0.450 |
| ArI-REM | 0.986 (0.968–1.004) | 0.128 | 0.986 (0.967–1.005) | 0.149 | 0.987 (0.968–1.005) | 0.162 |
| ArI-NREM | 1.005 (0.990–1.020) | 0.539 | 0.995 (0.978–1.014) | 0.623 | 0.995 (0.977–1.013) | 0.607 |
| Sleep duration | ||||||
| <6h | 1.943 (1.173–3.220) | 0.010 | 1.725 (1.026–2.899) | 0.040 | ||
| >8h | 1.326 (0.893–1.970) | 0.162 | 1.223 (0.816–1.833) | 0.330 | ||
| 6h–8h | 1(Ref) | 1(Ref) |
Notes: †Each individual sleep characteristics was adjusted by age, gender, smoking status, race, body mass index, prevalent hypertension and diabetes mellitus, apnea-hypopnea index, benzodiazepine use, alcohol use. ‡Adjusted by †plus sleep duration.
Abbreviations: ArI, arousal index; 95% CI, 95% confidence interval; HR, hazard ratio; NREM, non-rapid eye movement; REM, rapid eye movement; SFI, sleep fragmentation index; SL, sleep latency; SWS, slow wave sleep.
HRs and 95% CIs for Quartiles of WASO and SE Associated with Ischemic Stroke
| Univariable Models | Multivariable Adjusted† | Multivariable Adjusted‡ | ||||
|---|---|---|---|---|---|---|
| All Subjects | HR (95% CI) | P | HR (95% CI) | P | HR (95% CI) | P |
| WASO | ||||||
| Fourth quartile (>80 min) | 4.996 (2.600–9.597) | <0.001 | 3.298 (1.608–6.768) | 0.001 | 3.771 (1.805–7.877) | <0.001 |
| Third quartile (49.0min–80min) | 3.299 (1.675–6.496) | 0.001 | 2.749 (1.317–5.738) | 0.007 | 3.009 (1.433–6.317) | 0.004 |
| Second quartile (30.0min–48.5min) | 3.005 (1.519–5.945) | 0.002 | 2.933 (1.392–6.183) | 0.005 | 3.108 (1.470–6.568) | 0.003 |
| First quartile (<30.0 min) | 1(Ref) | 1(Ref) | 1(Ref) | |||
| Sleep efficiency | ||||||
| First quartile (<80.0%) | 3.726 (2.174–6.386) | <0.001 | 2.210 (1.241–3.936) | 0.007 | 2.220 (1.244–3.960) | 0.007 |
| Second quartile (80.0–84.9%) | 2.467 (1.332–4.569) | 0.004 | 1.859 (0.970–3.564) | 0.062 | 1.829 (0.952–3.514) | 0.070 |
| Third quartile (85.0–89.9%) | 1.866 (1.017–3.423) | 0.044 | 1.443 (0.762–2.732) | 0.261 | 1.457 (0.769–2.760) | 0.248 |
| Fourth quartile (≥90%) | 1(Ref) | 1(Ref) | 1(Ref) |
Notes: †Adjusted by age, gender, smoking status, race, body mass index, prevalent hypertension and diabetes mellitus, apnea-hypopnea index, benzodiazepine use, alcohol use. ‡Adjusted by †plus sleep duration.
Abbreviations: 95% CI, 95% confidence interval; HR, hazard ratio; WASO, wake after sleep onset.